Search research articles
Contact Us
Filters
Showing results (41-50 of 495) with videos related to
Page
of 50
Sort By:
Italian Journal of Neurological Sciences
|
September 1, 1994
Association of neuromyotonia with peripheral neuropathy, myasthenia gravis and thymoma: a case report
M Perini, A Ghezzi, P F Basso, et al.
European Neurology
|
January 1, 1987
The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis
C L Cazzullo, D Caputo, A Ghezzi, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1985
Pharmacokinetics of cefatrizine after oral administration in human volunteers
V Mastrandrea, S Ripa, F La Rosa, et al.
Journal of Neurology
|
January 1, 1984
A case of myasthenia gravis associated with optic neuritis
A Ghezzi, M Zaffaroni, D Caputo, et al.
Neurophysiologie Clinique = Clinical Neurophysiology
|
September 1, 1992
Perineal motor potentials to magnetic stimulation, pudendal evoked potentials and perineal reflex in women
A Ghezzi, L Callea, M Zaffaroni, et al.
Rivista Di Neurobiologia : Organo Ufficiale Della Societa Dei Neurologi, Neuroradiologi E Neurochirurghi Ospedalieri
|
July 1, 1981
[Visual evoked potentials in childhood: pathologic appearance]
A Ghezzi, A Giollo, O Orsini, et al.
Functional Neurology
|
February 21, 2002
Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion
A Dario, C Scamoni, G Bono, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 24, 2001
The prognosis of idiopathic optic neuritis
A Ghezzi, V Martinelli, M Rodegher, et al.
La Radiologia Medica
|
April 1, 1992
[Intestinal transit studied with radiopaque markers in patients with multiple sclerosis]
R Nicoletti, A Mina, G Balzaretti, et al.
European Journal of Neurology
|
November 29, 2013
Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up
A Ghezzi, M Zaffaroni, M Filippi, et al.
Page
of 50
Search research articles
Search
Showing results (41-50 of 495) with videos related to
Sort By:
Page
of 50
Italian Journal of Neurological Sciences
|
September 1, 1994
Association of neuromyotonia with peripheral neuropathy, myasthenia gravis and thymoma: a case report
M Perini, A Ghezzi, P F Basso, et al.
European Neurology
|
January 1, 1987
The role of lymphocyte subset analysis in defining the clinical evolution of multiple sclerosis
C L Cazzullo, D Caputo, A Ghezzi, et al.
International Journal of Clinical Pharmacology Research
|
January 1, 1985
Pharmacokinetics of cefatrizine after oral administration in human volunteers
V Mastrandrea, S Ripa, F La Rosa, et al.
Journal of Neurology
|
January 1, 1984
A case of myasthenia gravis associated with optic neuritis
A Ghezzi, M Zaffaroni, D Caputo, et al.
Neurophysiologie Clinique = Clinical Neurophysiology
|
September 1, 1992
Perineal motor potentials to magnetic stimulation, pudendal evoked potentials and perineal reflex in women
A Ghezzi, L Callea, M Zaffaroni, et al.
Rivista Di Neurobiologia : Organo Ufficiale Della Societa Dei Neurologi, Neuroradiologi E Neurochirurghi Ospedalieri
|
July 1, 1981
[Visual evoked potentials in childhood: pathologic appearance]
A Ghezzi, A Giollo, O Orsini, et al.
Functional Neurology
|
February 21, 2002
Functional improvement in patients with severe spinal spasticity treated with chronic intrathecal baclofen infusion
A Dario, C Scamoni, G Bono, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
February 24, 2001
The prognosis of idiopathic optic neuritis
A Ghezzi, V Martinelli, M Rodegher, et al.
La Radiologia Medica
|
April 1, 1992
[Intestinal transit studied with radiopaque markers in patients with multiple sclerosis]
R Nicoletti, A Mina, G Balzaretti, et al.
European Journal of Neurology
|
November 29, 2013
Natural interferon-beta in chronic progressive multiple sclerosis: results after 2 years of treatment and 2 years of follow up
A Ghezzi, M Zaffaroni, M Filippi, et al.
Page
of 50